After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Travere Therapeutics Inc is $1.75B. A total of 0.77 million shares were traded on the day, compared to an average of 1.32M shares.
In the most recent transaction, ROTE WILLIAM E. sold 2,437 shares of TVTX for 19.46 per share on Jan 22 ’25. After the transaction, the SENIOR VICE PRESIDENT, R&D now owns 83,170 company shares. In a previous transaction on Jan 22 ’25, Dube Eric M sold 10,736 shares at 19.46 per share. TVTX shares that CHIEF EXECUTIVE OFFICER owns now total 351,239.
Among the insiders who sold shares, REED ELIZABETH E disposed of 2,437 shares on Jan 22 ’25 at a per-share price of $19.46. This resulted in the SVP, GC & CORPORATE SECRETARY holding 76,933 shares of TVTX after the transaction. In another insider transaction, Baynes Roy D. sold 16,000 shares at $20.00 per share on Jan 23 ’25. Company shares held by the Director now total 31,000.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TVTX has a high of $21.56 and a low of $5.12.
As of this writing, TVTX has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.52.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TVTX’s latest balance sheet shows that the firm has $552.88M in Cash & Short Term Investments as of fiscal 2021. There were $261.99M in debt and $124.09M in liabilities at the time. Its Book Value Per Share was -$0.39, while its Total Shareholder’s Equity was $302.11M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TVTX is Buy with a score of 4.75.
